PANK4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.402600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.962600E-01
Normal-vs-Stage2
1.919780E-01
Normal-vs-Stage3
4.356300E-02
Normal-vs-Stage4
6.109000E-01
Stage1-vs-Stage2
5.123600E-01
Stage1-vs-Stage3
6.943500E-02
Stage1-vs-Stage4
7.510000E-01
Stage2-vs-Stage3
1.350830E-01
Stage2-vs-Stage4
3.867000E-01
Stage3-vs-Stage4
7.064200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.177200E-01
Normal-vs-AfricanAmerican
2.823400E-01
Normal-vs-Asian
7.448200E-01
Caucasian-vs-AfricanAmerican
6.979600E-01
Caucasian-vs-Asian
3.843000E-01
AfricanAmerican-vs-Asian
6.987200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.382440E-01
Normal-vs-Female
3.829200E-01
Male-vs-Female
1.981150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.810600E-01
Normal-vs-Age(41-60Yrs)
4.095400E-01
Normal-vs-Age(61-80Yrs)
2.017600E-01
Normal-vs-Age(81-100Yrs)
1.412210E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.638600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.525800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.394000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.863900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.506030E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.257400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.641840E-01
Normal-vs-Daily Drinker
7.328000E-02
Normal-vs-Weekly Drinker
4.931400E-01
Normal-vs-Occasional Drinker
7.151600E-01
Normal-vs-Social Drinker
2.940000E-01
Non Drinker-vs-Daily Drinker
7.270000E-01
Non Drinker-vs-Weekly Drinker
3.278400E-01
Non Drinker-vs-Occasional Drinker
8.627700E-02
Non Drinker-vs-Social Drinker
2.706600E-01
Daily Drinker-vs-Weekly Drinker
4.702400E-01
Daily Drinker-vs-Occasional Drinker
1.426170E-01
Daily Drinker-vs-Social Drinker
3.101000E-01
Weekly Drinker-vs-Occasional Drinker
5.946000E-01
Weekly Drinker-vs-Social Drinker
9.729200E-01
Occasional Drinker-vs-Social Drinker
5.084400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.341800E-01
Normal-vs-Grade 2
8.938400E-01
Normal-vs-Grade 3
8.816400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.780200E-01
Grade 1-vs-Grade 3
3.741600E-01
Grade 1-vs-Grade 4
9.341800E-01
Grade 2-vs-Grade 3
6.626800E-01
Grade 2-vs-Grade 4
8.938400E-01
Grade 3-vs-Grade 4
8.816400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.815820E-01
Normal-vs-NonDiabetic
2.853000E-01
Diabetic-vs-NonDiabetic
7.974400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.140200E-01
Normal-vs-NoPancreatitis
2.634000E-01
Pancreatitis-vs-NoPancreatitis
7.353000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.547000E-01
Normal-vs-N1
2.190200E-01
N0-vs-N1
8.467600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.570200E-01
Normal-vs-TP53-NonMutant
3.145800E-01
TP53-Mutant-vs-TP53-NonMutant
9.690400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
